Treatment of Crohn's Disease With an Antibiotic Regimen Directed Against Mycobacterium Avium Paratuberculosis
Status:
Withdrawn
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
Crohn's disease is a chronic inflammatory disorder of the gastrointestinal tract. The origin
of Crohn's disease remains unknown and there is no curative therapy, either medical or
surgical, for this gut disorder.
It is believed that an infectious agent is important in the development of Crohn's disease.
The similarity of Crohn's disease to the animal form of ileitis, termed Johne's disease,
supports the possibility that both disorders are caused by exposure to Mycobacterium avium
paratuberculosis or MAP. Multiple investigators have demonstrated good clinical responses of
patients with Crohn's disease to treatment with triple antibiotic therapy directed against
mycobacterial infection.
The hypothesis of this protocol is that triple antibiotic therapy is useful as a medical
therapy for patients with Crohn's disease. The aim of this study is to examine the response
of patients with Crohn's disease who are not receiving therapy with biological agents to
triple antibiotic therapy.